JRP-980

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameJRP-980
Drug Alias NameJRP-980
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT3 inhibitorsTyrosine-protein kinase SRC inhibitorsCyclooxygenase-1 inhibitors +[7] 
TargetsSerine/threonine-protein kinase AKT3Tyrosine-protein kinase SRCEpidermal growth factor receptor erbB1 +[7] 
Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProus Institute For Biomedical Research Sa
China Registration ClassN/A

Develop Information

Active CompaniesProus Institute For Biomedical Research Sa
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A